BVF II GP LLC

CIK 1803806 · last filed 2025-01-28

BVF II GP LLC is a corporate insider who has filed 9 SEC Form 4 insider transactions across 7 companies since 2020. The most recent filing shows the insider sold $169.8M of XOMAP on Jan 28, 2025. Across all open-market trades the lifetime net is −$2.54B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $52.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$52.72M

Companies

7

Total Filings

9

Lifetime Open-Market Net

-$2.54B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
XOMAP Director 0 $25.46 $0 -$159.93M 2 2025-01-28
OLMA Director 3,684,068 $9.87 $36.36M $0 1 2024-06-18
RAIN Director 0 $2.04 $0 $0 1 2024-01-29
POINT Biopharma Global Inc. (PNT) Delisted 0 $12.50 $0 -$2.14B 1 2023-12-20
CTI BIOPHARMA CORP (CTIC) Delisted Director 2,228,652 $9.09 $20.26M $0 2 2023-04-07
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted 5,663,912 $0.04 $253.2K -$242.06M 1 2021-01-26
XOMA 10%+ Owner 391,415 $41.79 $16.36M $1.42M 1 2020-03-27

Recent Filings

9 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-01-28 XOMAP Sell (S) −6,507,170 -$169.84M EDGAR
2024-06-18 OLMA Grant (A) $0 EDGAR
2024-01-29 RAIN Mixed −85,768,030 $0 EDGAR
2023-12-20 POINT Biopharma Global Inc. (PNT) Delisted Sell (S) −171,612,780 -$2.14B EDGAR
2023-04-07 CTI BIOPHARMA CORP (CTIC) Delisted Grant (A) $0 EDGAR
2022-09-16 XOMAP Buy (P) +563,090 $9.91M EDGAR
2021-01-26 INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Sell (S) −58,485,200 -$242.06M EDGAR
2020-03-27 XOMA Buy (P) +82,640 $1.42M EDGAR
2020-03-04 CTI BIOPHARMA CORP (CTIC) Delisted Mixed $0 EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.